CHA Joins End Drug Shortages Alliance

CHA Joins End Drug Shortages Alliance

CHA has joined a new coalition of diverse stakeholders to address drug shortages in the U.S.

Washington, D.C. – Children’s Hospital Association (CHA) has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of health care’s more pressing and enduring issues, drug shortages that disrupt patient care.

“Drug shortages disproportionately and uniquely impact children’s hospitals. We continue to work diligently to ensure the children our hospitals serve have needed resources to continue providing outstanding, safe and effective care for the nation’s most vulnerable and medically complex patients,” said Mark Wietecha, chief executive officer of CHA. The association also holds the vice-chair seat for the Alliance advisory board. “Our collaboration with the End Drug Shortages Alliance ensures a needed focus on pediatrics in this space.”

Launched in late 2021, the End Drug Shortages Alliance brings together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders and champions. Efforts will focus on improving access to medications through greater transparency across market participants, leading to improved quality manufacturing of medications and production of additional supply.

Learn more at www.EndDrugShortages.com.

About Children's Hospital Association

Children’s Hospital Association is the national voice of more than 220 children’s hospitals, advancing child health through innovation in the quality, cost and delivery of care.